Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Simone Patergnani
 + 2393 word(s) 2393 2021-11-16 07:03:44 |
2 Done
Jason Zhu
 Meta information modification 2393 2021-12-20 03:13:30 |

Video Upload Options

We provide professional Video Production Services to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Patergnani, S. Molecular Mechanisms of Autophagy. Encyclopedia. Available online: https://encyclopedia.pub/entry/17251 (accessed on 04 December 2024).
Patergnani S. Molecular Mechanisms of Autophagy. Encyclopedia. Available at: https://encyclopedia.pub/entry/17251. Accessed December 04, 2024.
Patergnani, Simone. "Molecular Mechanisms of Autophagy" Encyclopedia, https://encyclopedia.pub/entry/17251 (accessed December 04, 2024).
Patergnani, S. (2021, December 17). Molecular Mechanisms of Autophagy. In Encyclopedia. https://encyclopedia.pub/entry/17251
Patergnani, Simone. "Molecular Mechanisms of Autophagy." Encyclopedia. Web. 17 December, 2021.
Molecular Mechanisms of Autophagy
Edit
This entry is adapted from the peer-reviewed paper 10.3390/cancers13225622

Autophagy is a main catabolic mechanism of the cell and refers to an evolutionary process by which cellular components and damaged organelles are degraded or recycled through lysosomal activity. Autophagy contributes to preserve cellular homeostasis and provides the cells the ability to adapt to stressful conditions and prevent cellular damage and cell death.

autophagy tumor suppression Mechanisms mitophagy

1. Introduction

Autophagy is a main catabolic mechanism of the cell and refers to an evolutionary process by which cellular components and damaged organelles are degraded or recycled through lysosomal activity. Autophagy contributes to preserve cellular homeostasis and provides the cells the ability to adapt to stressful conditions and prevent cellular damage and cell death. Autophagy not only occurs as a response to various stress signals but also happens at basal levels where it regulates the cellular and tissue development and cell survival/death events [1]. Thanks to these features, today, autophagy is a tightly regulated mechanism involved in diverse pathologies, in particular in cancer, where more than 100 clinical trials associated with autophagy modulation have been conducted or are active. Despite the majority of these clinical trials expecting to induce a blocking of the autophagy machinery, the effective role of autophagy in cancer still remains controversial. For some malignancies, autophagy is a cytoprotective mechanism that increases the tumor cell viability and growth. Cancer cells within tumors are characterized by hypoxic conditions and nutrient deprivation. Thanks to the recycling of cytoplasmic elements provided by autophagy, cancer cells can survive these stressful conditions. Furthermore, autophagy has also been found to reduce the cellular stress induced by chemotherapy agents. On the other hand, autophagy is also described as a mechanism for the suppression of cancer. In this case, autophagy eliminates dangerous cellular elements, preserves the genomics stability, and activates the immunoresponse processes toward malignant transformation. Overall, a deep understanding of the connections that exist between autophagy and cancer, together with a clear identification of the molecular mechanisms characterizing this axis, are crucial to develop an appropriate therapeutic approach based on autophagy modulation in cancer.

2. General Aspects of Autophagy and Molecular Mechanisms

The term autophagy (Greek, “self-eating”) refers to a tightly evolutionary self-degradation system that is essential for the maintenance of the physiological homeostasis that occurs in response to several cellular and environmental stresses [2]. Over the past ten years, substantial research has been carried out in regard to understanding the regulation and molecular mechanisms of autophagy, and considerable interest has emerged in this area of research, enough to confer the Nobel Prize in Medicine or Physiology to Yoshinori Oshumi for his groundbreaking work on the autophagic mechanism [3].
In mammalian cells, at least three distinct forms of autophagy—macroautophagy, microautophagy, and chaperone-mediated autophagy (CMA)—can be distinguished based on the mode of cargo delivery to lysosomes. During microautophagy, the lysosomal membrane can directly invaginate to trap cytosolic cargo for degradation; this process can include intact organelles and can be defined in different terms, such as micromitophagy (for mitochondria), microlipophagy (for lipid droplets), and micropexophagy (for peroxisomes) [4]. CMA uses chaperones to identify cargo proteins containing a specific pentapeptide-targeting motif (KFERQ), which is recognized by heat shock cognate 71 kDa protein (HSC70) in the cytosol, that are targeted and bound to the lysosomal membrane protein LAMP2A [5]. In contrast, macroautophagy (hereafter referred to as autophagy) involves the sequestration of cytoplasmic cargo by de novo double-membrane vesicles (named autophagosomes) that ultimately fuse to lysosomes for degradation [6].
Autophagy is a highly catabolic process, conserved from yeast to humans, used by eukaryotic cells to maintain cellular homeostasis and cellular and organellar quality control in response to multiple forms of stress, including energy or nutrients deprivation, hypoxia, oxidative stress, endoplasmic reticulum (ER) stress, and infection [7][8][9].
From a molecular point of view (Figure 1), autophagy can be divided into four critical steps: initiation, nucleation, maturation, and degradation, strictly orchestrated by at least 37-autophagy-related proteins (ATGs), that deliver cytoplasmic cargo to the lysosome for degradation. Two nutrient-responsive kinases, 5′ AMP-activated protein kinase (AMPK) and mechanistic target of rapamycin (MTOR), are the main regulators (positive and negative, respectively) of autophagy and quickly respond to external stimuli, nutrient fluctuations, and phosphorylation/dephosphorylation events. AMPK is a heterotrimeric protein that acts as a monitor of intracellular energy levels by controlling the AMP/ATP ratio. AMPK also controls the cellular processes that increase the ATP amounts (such as glycolysis and β-oxidation), controls the fatty acids and cholesterol synthesis, and regulates the ATP-consuming mechanisms [10][11]. MTOR is a serine/threonine protein kinase belonging to the phosphatidylinositol kinase-related kinase (PIKK) family. Inside the cell, MTOR is found in two distinct complexes, MTORC1 and MTORC2, but only MTORC1 regulates the cellular metabolism and responds to external and internal signals, such as amino acids, glucose, and growth factors [12]. Apart from MTOR itself, MTORC1 is composed of various regulatory subunits (including Raptor, MLST8, PRAS40, and DEPTOR) [13], and, under physiological conditions, MTORC1 results in activity and represses the autophagy machinery by phosphorylating the unc-51-like kinase 1 (ULK1) serine threonine kinase complex (consisting of ULK1, ATG13, RIB-inducible coiled-coil protein 1 (FIP200), and ATG101) at Ser-757, Ser-638, and Ser-758 residues [14][15]. The inactivation of MTORC1 causes the dephosphorylation of the target ribosomal protein S6 kinase (p70S6K) and the translation initiation factor 4E binding protein-1 (4E-BP1), provoking a downregulation of the cellular protein synthesis translation and the activation of the autophagy-dependent self-digestive process. In this latter event, the AMPK inhibits MTORC1 directly by phosphorylating Raptor [16] and indirectly via the activation of the tuberous sclerosis 2 (TSC2) complex [17] to determine the dephosphorylation of ULK1 at Ser-757, Ser-638, and Ser-758 residues. Then, the AMPK phosphorylates ULK1 and ATG13 in specific amino acid residues (Ser-555, Ser-777, Ser-317, Ser-467) to activate the ULK1 complex [14].
Cancers 13 05622 g001 550
Figure 1. Molecular aspects of autophagy. Autophagy is a catabolic process used by eukaryotic cells to maintain cellular homeostasis and cellular and organellar quality control in response to multiple forms of stress. Different factors are involved during the main stages of autophagy. During the initiation step, the Unc-51-like kinase 1 (ULK1) serine threonine kinase complex receives input from the mechanistic target of rapamycin (MTOR) and from the kinase 5′ AMP-activated protein kinase (AMPK). Meanwhile, MTOR is the main autophagic repressor; AMPK is an autophagy activator. The ULK1 complex then activates nucleation of the phagophore by activating members of class III phosphatidylinositol 3 kinase (PI3KC3) complexes, such as AMBRA1, VSP34, and BECN1. BCL2 regulates the activity of BECN1. Ubiquitin-like conjugation systems ATG12-ATG5-ATG16 and LC3-ATG4 are necessary for the maturation of the vesicle. Other proteins, such as p62, complete the autophagosome formation. The last phase is characterized by fusion of the autophagosome with lysosome and the degradation of the autophagic cargo by acidic hydrolases.
The ULK1 complex activation represents the initiation step of autophagy [18] and triggers the nucleation of the phagophore by phosphorylating and activating class III phosphatidylinositol 3 kinase (PI3KC3) complexes. The core of the PI3KC3 complex consists of class III PI3K, BECN1 [19], vacuolar protein sorting 34 (VSP34) [20], and general vesicular transport factor (p115) [21], then it can be associated with both ATG14 [22] and the activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) (PI3KC3-C1) [23] or UV radiation resistance-associated gene protein (UVRAG) (PI3KC3-C2) [19], which both, in turn, generate local phosphatidylinositol-3-phosphate (PIP3) production at a characteristic ER structure called the omegasomes, the membranous regions that elongate to generate the phagophores [24]. Both the initiation and nucleation steps promote the formation of the autophagic vesicle membrane that can also include membranes from ER-mitochondria and ER-plasma membrane contact sites, mitochondria, recycling endosomes, and Golgi complex [25][26], as well as ATG9-containing vesicles. PIP3 then recruits, through the PIP3-binding domain, WD repeat domain phosphoinositide-interacting proteins (WIPI) and zinc-finger FYVE domain-containing protein 1 (DFCP1) to promote membrane elongation [27]. This process represents the transition from omegasomes to the phagophores.
Two ubiquitin (Ub)-like conjugation systems are necessary for autophagosome formation (maturation step). One system involves the covalent conjugation of the Ub-like mammalian ATG12 to ATG5, which, together with RAB37 [28], further establishes a complex with ATG16, which, in turn, links to WIPI2 [27] and associates with the phagophore membrane. Although ATG7 and ATG5 represent fundamental proteins for autophagy execution, recent investigations have unveiled that autophagy may also occur in Atg5 or Atg7-deficient cells. In this case, autophagy is termed “alternative autophagy” and the elongation process depends on the activity of RAB9 GTPase [29]. The second pathway, the ATG8 family proteins, includes microtubule-associated protein 1A/B light-chain 3A (LC3) and the GABARAP (gamma-aminobutyric acid receptor-associated protein) subfamily to membrane-resident phosphatidylethanolamine (PE) thanks to the sequential action of the proteases ATG4 and ATG3 [30]. These complexes, both regulated by the E1-like enzyme ATG7, bring the conversion of the soluble form of LC3 (LC3-I) to the lipidated autophagic vesicles-associated form, known as LC3-II. LC3-II is one of the most commonly used markers of autophagy as it migrates faster than LC3-I by electrophoresis detection; additionally, green fluorescent protein-LC3 fusion protein can be used to detect autophagosomes shifting from diffuse to punctuate staining by microscopy [2]. The lipidation process of LC3 is critical for the expansion and closure of the phagophore. However, during this process, it has been unveiled that the association of WIPI4 with ATG2, which together recruit ATG9, is essential. Indeed, the WIPI4–ATG2 complex moves to the ER and mediates the tethering between the ER and phagophore to regulate the lipid transfers necessary for the expansion of the phagophore [31]. Furthermore, ATG9, whose recruitment to ER is determined by the WIPI4–ATG2 complex, is equally important for the lipid and membrane supply to the phagophore [32][33].
The closure of the autophagic vesicle engages members of the endosomal sorting complex required for transport (ESCRT), in particular the charged multivesicular body protein 2A (CHMP2A) and the vacuolar protein sorting-associated-4 (VPS4) [34]. Both proteins move on the outer leaf of the autophagic vesicle, but, meanwhile, CHMP2A is responsible for the closure of the autophagosome, and VSP4 determines the disassembly of ESCRT molecules. Consistent with this, the genetic inhibition of CHMP2A and VPS4 alters the closure of the vesicle and delays fusion with the lysosome [34].
The newly formed double-membrane vesicle, just termed autophagosome, traps the engulfed cytosolic material, recruited by cargo receptors, such as SQSTM1/P62 and NBR1, as autophagic cargo destinated for degradation [35]. Then, the autophagosome is transported along microtubules to the perinuclear region to fuse with lysosomal membranes and form an autophagolysosome. This event requires the changing in lysosomal pH, tethering factors, such as the multiprotein homotypic fusion and vacuole protein sorting (HOPS) complex, RAB7, and small GTPase, along with SNAREs proteins (syntaxin 17 (STX17) and synaptosomal-associated protein 29 (SNAP29) in the autophagosome and vesicle associated membrane protein 8 on the lysosome (VAMP8) [36][37]. Emerging evidence suggests that other proteins, such as the adaptor protein EPG5 and members of the LC3/GABARAP family, are involved in the autophagosome–lysosome fusion event [38][39].
The last phase encompasses the degradation of the autophagic cargo by acidic hydrolases in the lysosome, and the resulting breakdown products are released back to the cytoplasm to provide new sources of energy in response to the nutritional needs of the cell (Figure 1).
Autophagy also exists in multiple variant forms that are characterized to sequester and degrade specific intracellular elements, such as proteins (proteinphagy), lipid droplet (lipophagy), xenobiotics (xenophagy), and organelles. Probably, the most studied selective form of autophagy toward an intracellular organelle is mitophagy, the autophagic removal of autophagy, which is an essential mitochondrial quality control mechanism [40]. Mitophagy may occur under physiological conditions (development, aging, and differentiation), it may be induced by diverse harmful conditions, such as loss of mitochondrial functioning, excessive reactive oxygen species (ROS) production, hypoxia, and accumulation of unfolded proteins, and it is involved during the pathogenesis of a number of human diseases, including neurodegeneration [41], cancer [42], and cardiovascular disease [43]. The possibility that, inside a cell, mitochondria could be removed was suggested in late 1915 [44] and confirmed in 1962 when, by using electron microscopy, mitochondrial fragments were identified in liver lysosomes [45]. However, the molecular mechanisms at the basis of mitophagy started to be unveiled in the early 2000s when it was demonstrated that, during the differentiative process, red blood cells [46][47][48] eliminate their mitochondria by a mechanism orchestrated by the OMM resident NIP3-like protein X (NIX/BNIP3L), which, thanks to a WXXL-like motif facing the cytosol, can bind LC3 and GABARAP proteins to recruit isolation membranes to mitochondria [49][50]. FUN14 domain-containing protein 1 (FUNDC1) represents another OMM protein that acts as a mitophagy receptor in response to determinate stimuli [51]. Under normal physiological conditions, SRC kinase phosphorylates FUNDC1. Upon hypoxia, SRC becomes inactivated and FUNDC1 is subsequently dephosphorylated. This results in an increase in association with LC3 and the incorporation of the damaged mitochondria into the autophagic vesicle [51]. However, probably, the best characterized molecular axis regulating mitophagy in mammals is the PTEN-induced kinase 1 (PINK1) and Parkinson protein 2 (parkin). In functional mitochondria, PINK1 is imported into the mitochondria in the IMM, processed by several protease, and then degraded by the proteasome. Following mitochondria uncoupling, PINK1 accumulates and stabilizes on the OMM where it phosphorylates Parkin to change its conformation, recruits Parkin on the mitochondria, and activates Parkin into an active phospho-Ub-dependent enzyme [52][53][54][55]. In this state, Parkin determines the ubiquitinization of diverse OMM proteins and the consequent recruitment of the Ub-binding autophagic receptors LC3, NBR1, MDP52, TAX1BP1 (TBK1), and p62/Sequestome [56][57]. Interestingly, it has been proven that, during Parkin-mediated mitophagy, the OMM results ruptured [55][58][59], and the IMM is potentially exposed to interaction with the autophagic vesicle. A recent work identifies the IMM protein prohibitin 2 (PHB2) as a crucial mitophagy receptor and demonstrates that PHB2 binds the LC3-interaction region (LIR) domain following the mitochondrial depolarization and proteasome-dependent rupture of the OMM [60]. Another IMM protein responsible for the regulation of mitophagy is cardiolipin (CL). Following mitophagy stimuli, CL translocates to the OMM and acts as a signal for the identification and elimination of harmed mitochondria [61]. Furthermore, it has been demonstrated that this process is facilitated by the fact that an LC3 protein possesses a CL-binding site [61]. Recent investigations also account for mitochondrial matrix proteins having an important role in mitophagy regulation. An example may be found in the nod-like receptor (NLR) family member NLRX1. NLRX1 contains a LIR domain, and, upon infection with the pathogen Listeria, oligomerizes to induce the binding of the LIR motif to LC3 to activate mitophagy [62]. Recently, two other mitochondrial matrix resident proteins have been associated with mitophagy regulation and activation in yeast. Consistently, a knockout of both mitochondrial kinases Pkp1 and Pkp2 abolishes the mitophagy program [63].

References

  1. Patergnani, S.; Missiroli, S.; Marchi, S.; Giorgi, C. Mitochondria-Associated Endoplasmic Reticulum Membranes Microenvironment: Targeting Autophagic and Apoptotic Pathways in Cancer Therapy. Front. Oncol. 2015, 5, 173.
  2. Klionsky, D.J.; Abdel-Aziz, A.K.; Abdelfatah, S.; Abdellatif, M.; Abdoli, A.; Abel, S.; Abeliovich, H.; Abildgaard, M.H.; Abudu, Y.P.; Acevedo-Arozena, A.; et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1). Autophagy 2021, 17, 1–382.
  3. Levine, B.; Klionsky, D.J. Autophagy wins the 2016 Nobel Prize in Physiology or Medicine: Breakthroughs in baker’s yeast fuel advances in biomedical research. Proc. Natl. Acad. Sci. USA 2017, 114, 201–205.
  4. Tekirdag, K.; Cuervo, A.M. Chaperone-mediated autophagy and endosomal microautophagy: Joint by a chaperone. J. Biol. Chem. 2018, 293, 5414–5424.
  5. Kaushik, S.; Cuervo, A.M. The coming of age of chaperone-mediated autophagy. Nat. Rev. Mol. Cell Biol. 2018, 19, 365–381.
  6. Dikic, I.; Elazar, Z. Mechanism and medical implications of mammalian autophagy. Nat. Rev. Mol. Cell Biol. 2018, 19, 349–364.
  7. Chipurupalli, S.; Kannan, E.; Tergaonkar, V.; D’Andrea, R.; Robinson, N. Hypoxia Induced ER Stress Response as an Adaptive Mechanism in Cancer. Int. J. Mol. Sci. 2019, 20, 749.
  8. Rashid, H.O.; Yadav, R.K.; Kim, H.R.; Chae, H.J. ER stress: Autophagy induction, inhibition and selection. Autophagy 2015, 11, 1956–1977.
  9. He, L.; Zhang, J.; Zhao, J.; Ma, N.; Kim, S.W.; Qiao, S.; Ma, X. Autophagy: The Last Defense against Cellular Nutritional Stress. Adv. Nutr. 2018, 9, 493–504.
  10. Shaw, R.J.; Kosmatka, M.; Bardeesy, N.; Hurley, R.L.; Witters, L.A.; DePinho, R.A.; Cantley, L.C. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. USA 2004, 101, 3329–3335.
  11. Hardie, D.G. AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy. Nat. Rev. Mol. Cell Biol. 2007, 8, 774–785.
  12. Szwed, A.; Kim, E.; Jacinto, E. Regulation and metabolic functions of mTORC1 and mTORC2. Physiol. Rev. 2021, 101, 1371–1426.
  13. Laplante, M.; Sabatini, D.M. mTOR signaling in growth control and disease. Cell 2012, 149, 274–293.
  14. Kim, J.; Kundu, M.; Viollet, B.; Guan, K.L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 2011, 13, 132–141.
  15. Shang, L.; Chen, S.; Du, F.; Li, S.; Zhao, L.; Wang, X. Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK. Proc. Natl. Acad. Sci. USA 2011, 108, 4788–4793.
  16. Son, S.M.; Park, S.J.; Stamatakou, E.; Vicinanza, M.; Menzies, F.M.; Rubinsztein, D.C. Leucine regulates autophagy via acetylation of the mTORC1 component raptor. Nat. Commun. 2020, 11, 3148.
  17. Tripathi, D.N.; Chowdhury, R.; Trudel, L.J.; Tee, A.R.; Slack, R.S.; Walker, C.L.; Wogan, G.N. Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2-mediated suppression of mTORC1. Proc. Natl. Acad. Sci. USA 2013, 110, E2950–E2957.
  18. Hosokawa, N.; Hara, T.; Kaizuka, T.; Kishi, C.; Takamura, A.; Miura, Y.; Iemura, S.; Natsume, T.; Takehana, K.; Yamada, N.; et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol. Biol. Cell 2009, 20, 1981–1991.
  19. Liang, C.; Feng, P.; Ku, B.; Dotan, I.; Canaani, D.; Oh, B.H.; Jung, J.U. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat. Cell Biol. 2006, 8, 688–699.
  20. Stjepanovic, G.; Baskaran, S.; Lin, M.G.; Hurley, J.H. Vps34 Kinase Domain Dynamics Regulate the Autophagic PI 3-Kinase Complex. Mol. Cell 2017, 67, 528–534.e523.
  21. Klionsky, D.J.; Baehrecke, E.H.; Brumell, J.H.; Chu, C.T.; Codogno, P.; Cuervo, A.M.; Debnath, J.; Deretic, V.; Elazar, Z.; Eskelinen, E.L.; et al. A comprehensive glossary of autophagy-related molecules and processes (2nd edition). Autophagy 2011, 7, 1273–1294.
  22. Itakura, E.; Kishi, C.; Inoue, K.; Mizushima, N. Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol. Biol. Cell 2008, 19, 5360–5372.
  23. Cianfanelli, V.; Fuoco, C.; Lorente, M.; Salazar, M.; Quondamatteo, F.; Gherardini, P.F.; De Zio, D.; Nazio, F.; Antonioli, M.; D’Orazio, M.; et al. AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation. Nat. Cell Biol. 2015, 17, 20–30.
  24. Axe, E.L.; Walker, S.A.; Manifava, M.; Chandra, P.; Roderick, H.L.; Habermann, A.; Griffiths, G.; Ktistakis, N.T. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J. Cell Biol. 2008, 182, 685–701.
  25. Ravikumar, B.; Moreau, K.; Jahreiss, L.; Puri, C.; Rubinsztein, D.C. Plasma membrane contributes to the formation of pre-autophagosomal structures. Nat. Cell Biol. 2010, 12, 747–757.
  26. Hailey, D.W.; Rambold, A.S.; Satpute-Krishnan, P.; Mitra, K.; Sougrat, R.; Kim, P.K.; Lippincott-Schwartz, J. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 2010, 141, 656–667.
  27. Dooley, H.C.; Razi, M.; Polson, H.E.; Girardin, S.E.; Wilson, M.I.; Tooze, S.A. WIPI2 links LC3 conjugation with PI3P, autophagosome formation, and pathogen clearance by recruiting Atg12-5-16L1. Mol. Cell 2014, 55, 238–252.
  28. Sheng, Y.; Song, Y.; Li, Z.; Wang, Y.; Lin, H.; Cheng, H.; Zhou, R. RAB37 interacts directly with ATG5 and promotes autophagosome formation via regulating ATG5-12-16 complex assembly. Cell Death Differ. 2018, 25, 918–934.
  29. Arakawa, S.; Honda, S.; Yamaguchi, H.; Shimizu, S. Molecular mechanisms and physiological roles of Atg5/Atg7-independent alternative autophagy. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2017, 93, 378–385.
  30. Wesch, N.; Kirkin, V.; Rogov, V.V. Atg8-Family Proteins-Structural Features and Molecular Interactions in Autophagy and Beyond. Cells 2020, 9, 2008.
  31. Chowdhury, S.; Otomo, C.; Leitner, A.; Ohashi, K.; Aebersold, R.; Lander, G.C.; Otomo, T. Insights into autophagosome biogenesis from structural and biochemical analyses of the ATG2A-WIPI4 complex. Proc. Natl. Acad. Sci. USA 2018, 115, E9792–E9801.
  32. Graef, M.; Friedman, J.R.; Graham, C.; Babu, M.; Nunnari, J. ER exit sites are physical and functional core autophagosome biogenesis components. Mol. Biol. Cell 2013, 24, 2918–2931.
  33. Orsi, A.; Razi, M.; Dooley, H.C.; Robinson, D.; Weston, A.E.; Collinson, L.M.; Tooze, S.A. Dynamic and transient interactions of Atg9 with autophagosomes, but not membrane integration, are required for autophagy. Mol. Biol. Cell 2012, 23, 1860–1873.
  34. Takahashi, Y.; He, H.; Tang, Z.; Hattori, T.; Liu, Y.; Young, M.M.; Serfass, J.M.; Chen, L.; Gebru, M.; Chen, C.; et al. An autophagy assay reveals the ESCRT-III component CHMP2A as a regulator of phagophore closure. Nat. Commun. 2018, 9, 2855.
  35. Lamark, T.; Kirkin, V.; Dikic, I.; Johansen, T. NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell Cycle 2009, 8, 1986–1990.
  36. Diao, J.; Liu, R.; Rong, Y.; Zhao, M.; Zhang, J.; Lai, Y.; Zhou, Q.; Wilz, L.M.; Li, J.; Vivona, S.; et al. ATG14 promotes membrane tethering and fusion of autophagosomes to endolysosomes. Nature 2015, 520, 563–566.
  37. Itakura, E.; Kishi-Itakura, C.; Mizushima, N. The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell 2012, 151, 1256–1269.
  38. Kriegenburg, F.; Ungermann, C.; Reggiori, F. Coordination of Autophagosome-Lysosome Fusion by Atg8 Family Members. Curr. Biol. CB 2018, 28, R512–R518.
  39. Wang, Z.; Miao, G.; Xue, X.; Guo, X.; Yuan, C.; Wang, Z.; Zhang, G.; Chen, Y.; Feng, D.; Hu, J.; et al. The Vici Syndrome Protein EPG5 Is a Rab7 Effector that Determines the Fusion Specificity of Autophagosomes with Late Endosomes/Lysosomes. Mol. Cell 2016, 63, 781–795.
  40. Patergnani, S.; Bonora, M.; Bouhamida, E.; Danese, A.; Marchi, S.; Morciano, G.; Previati, M.; Pedriali, G.; Rimessi, A.; Anania, G.; et al. Methods to Monitor Mitophagy and Mitochondrial Quality: Implications in Cancer, Neurodegeneration, and Cardiovascular Diseases. Methods Mol. Biol. 2021, 2310, 113–159.
  41. Patergnani, S.; Bonora, M.; Ingusci, S.; Previati, M.; Marchi, S.; Zucchini, S.; Perrone, M.; Wieckowski, M.R.; Castellazzi, M.; Pugliatti, M.; et al. Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis. Proc. Natl. Acad. Sci. USA 2021, 118, e2020078118.
  42. Vara-Perez, M.; Felipe-Abrio, B.; Agostinis, P. Mitophagy in Cancer: A Tale of Adaptation. Cells 2019, 8, 493.
  43. Morciano, G.; Patergnani, S.; Pedriali, G.; Cimaglia, P.; Mikus, E.; Calvi, S.; Albertini, A.; Giorgi, C.; Campo, G.; Ferrari, R.; et al. Impairment of mitophagy and autophagy accompanies calcific aortic valve stenosis favoring cell death and the severity of disease. Cardiovasc. Res. 2021.
  44. Lewis, M.R.; Lewis, W.H. Mitochondria (and other cytoplasmic structures) in tissue cultures. Am. J. Anat. 1915, 17, 339–401.
  45. Ashford, T.P.; Porter, K.R. Cytoplasmic components in hepatic cell lysosomes. J. Cell Biol. 1962, 12, 198–202.
  46. Zhang, J.; Randall, M.S.; Loyd, M.R.; Dorsey, F.C.; Kundu, M.; Cleveland, J.L.; Ney, P.A. Mitochondrial clearance is regulated by Atg7-dependent and -independent mechanisms during reticulocyte maturation. Blood 2009, 114, 157–164.
  47. Mortensen, M.; Ferguson, D.J.; Edelmann, M.; Kessler, B.; Morten, K.J.; Komatsu, M.; Simon, A.K. Loss of autophagy in erythroid cells leads to defective removal of mitochondria and severe anemia in vivo. Proc. Natl. Acad. Sci. USA 2010, 107, 832–837.
  48. Aerbajinai, W.; Giattina, M.; Lee, Y.T.; Raffeld, M.; Miller, J.L. The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation. Blood 2003, 102, 712–717.
  49. Yuan, Y.; Zheng, Y.; Zhang, X.; Chen, Y.; Wu, X.; Wu, J.; Shen, Z.; Jiang, L.; Wang, L.; Yang, W.; et al. BNIP3L/NIX-mediated mitophagy protects against ischemic brain injury independent of PARK2. Autophagy 2017, 13, 1754–1766.
  50. Novak, I.; Kirkin, V.; McEwan, D.G.; Zhang, J.; Wild, P.; Rozenknop, A.; Rogov, V.; Lohr, F.; Popovic, D.; Occhipinti, A.; et al. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep 2010, 11, 45–51.
  51. Liu, L.; Feng, D.; Chen, G.; Chen, M.; Zheng, Q.; Song, P.; Ma, Q.; Zhu, C.; Wang, R.; Qi, W.; et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol. 2012, 14, 177–185.
  52. Jin, S.M.; Lazarou, M.; Wang, C.; Kane, L.A.; Narendra, D.P.; Youle, R.J. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J. Cell Biol. 2010, 191, 933–942.
  53. Yamano, K.; Youle, R.J. PINK1 is degraded through the N-end rule pathway. Autophagy 2013, 9, 1758–1769.
  54. Lazarou, M.; Jin, S.M.; Kane, L.A.; Youle, R.J. Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin. Dev. Cell 2012, 22, 320–333.
  55. Lazarou, M.; Sliter, D.A.; Kane, L.A.; Sarraf, S.A.; Wang, C.; Burman, J.L.; Sideris, D.P.; Fogel, A.I.; Youle, R.J. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 2015, 524, 309–314.
  56. Geisler, S.; Holmstrom, K.M.; Skujat, D.; Fiesel, F.C.; Rothfuss, O.C.; Kahle, P.J.; Springer, W. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 2010, 12, 119–131.
  57. Pickles, S.; Vigie, P.; Youle, R.J. Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance. Curr. Biol. CB 2018, 28, R170–R185.
  58. Chan, N.C.; Salazar, A.M.; Pham, A.H.; Sweredoski, M.J.; Kolawa, N.J.; Graham, R.L.; Hess, S.; Chan, D.C. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum. Mol. Genet. 2011, 20, 1726–1737.
  59. Yoshii, S.R.; Kishi, C.; Ishihara, N.; Mizushima, N. Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J. Biol. Chem. 2011, 286, 19630–19640.
  60. Wei, Y.; Chiang, W.C.; Sumpter, R., Jr.; Mishra, P.; Levine, B. Prohibitin 2 Is an Inner Mitochondrial Membrane Mitophagy Receptor. Cell 2017, 168, 224–238.e210.
  61. Chu, C.T.; Ji, J.; Dagda, R.K.; Jiang, J.F.; Tyurina, Y.Y.; Kapralov, A.A.; Tyurin, V.A.; Yanamala, N.; Shrivastava, I.H.; Mohammadyani, D.; et al. Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat. Cell Biol. 2013, 15, 1197–1205.
  62. Zhang, Y.; Yao, Y.; Qiu, X.; Wang, G.; Hu, Z.; Chen, S.; Wu, Z.; Yuan, N.; Gao, H.; Wang, J.; et al. Listeria hijacks host mitophagy through a novel mitophagy receptor to evade killing. Nat. Immunol. 2019, 20, 433–446.
  63. Kolitsida, P.; Zhou, J.; Rackiewicz, M.; Nolic, V.; Dengjel, J.; Abeliovich, H. Phosphorylation of mitochondrial matrix proteins regulates their selective mitophagic degradation. Proc. Natl. Acad. Sci. USA 2019, 116, 20517–20527.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Cell Biology
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Simone Patergnani
View Times: 568
Revisions: 2 times (View History)
Update Date: 20 Dec 2021
Table of Contents
    1000/1000
    Hot Most Recent
    ScholarVision Creations
    Feedback